0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radiopharmaceutical Injector Market Research Report 2026
Published Date: 2026-04-18
|
Report Code: QYRE-Auto-30A614
Home | Market Reports | Autos & Vehicles| Vehicle Parts & Services| Vehicle Parts & Accessories
Global Radiopharmaceutical Injector Market Insights and Forecast to 2028
BUY CHAPTERS

Global Radiopharmaceutical Injector Market Research Report 2026

Code: QYRE-Auto-30A614
Report
2026-04-18
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Radiopharmaceutical Injector Market Size

The global Radiopharmaceutical Injector market was valued at US$ 34.29 million in 2025 and is anticipated to reach US$ 55.96 million by 2032, at a CAGR of 7.4% from 2026 to 2032.

Radiopharmaceutical Injector Market

Radiopharmaceutical Injector Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Radiopharmaceutical Injector competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A radiopharmaceutical injector is a medical device used to administer radiopharmaceuticals to patients. Radiopharmaceuticals are drugs that contain radioactive isotopes, which emit gamma rays or positrons that can be detected by specialized imaging equipment. These drugs are used in nuclear medicine for diagnostic imaging and therapy.
The radiopharmaceutical injector is specifically designed to safely and accurately deliver these radioactive drugs into the patient"s body. It ensures precise control over the injection process, including the injection rate, volume, and timing. This control is crucial to ensure optimal distribution of the radiopharmaceutical within the patient"s body and accurate imaging or therapeutic results.
Global key players of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN and Comecer, etc. The top three players hold a share over 65%. Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in the world, has a share about 30%. Europe is the largest market, has a share about 35%. In terms of product type, PET Radioactive Drugs Injector is the largest segment, occupied for a share of 85%, and in terms of application, Hospitals and Clinics has a share about 80 percent.
This report delivers a comprehensive overview of the global Radiopharmaceutical Injector market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Radiopharmaceutical Injector. The Radiopharmaceutical Injector market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Radiopharmaceutical Injector market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Radiopharmaceutical Injector manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Radiopharmaceutical Injector Market Report

Report Metric Details
Report Name Radiopharmaceutical Injector Market
Accounted market size in 2025 US$ 34.29 million
Forecasted market size in 2032 US$ 55.96 million
CAGR 7.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • PET Radioactive Drugs Injector
  • PET and SPECT Radioactive Drugs Injector
by Application
  • Hospitals and Clinics
  • R&D Institution
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medrad, Inc.(Bayer), UNIVERSAL GIKEN, Comecer, Sumitomo Heavy Industries, Tema Sinergie, Lemer Pax, BQSV
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Radiopharmaceutical Injector manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Radiopharmaceutical Injector sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Radiopharmaceutical Injector Market growing?

Ans: The Radiopharmaceutical Injector Market witnessing a CAGR of 7.4% during the forecast period 2026-2032.

What is the Radiopharmaceutical Injector Market size in 2032?

Ans: The Radiopharmaceutical Injector Market size in 2032 will be US$ 55.96 million.

What is the market share of major companies in Radiopharmaceutical Injector Market?

Ans: The top three players hold a share over 65%.

What is the Medrad, Inc.(Bayer) share in Radiopharmaceutical Injector Market?

Ans: Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in the world, has a share about 30%.

What is the Radiopharmaceutical Injector Market share by region?

Ans: Europe is the largest market, has a share about 35%.

What is the Radiopharmaceutical Injector Market share by type?

Ans: In terms of product type, PET Radioactive Drugs Injector is the largest segment, occupied for a share of 85%, and in terms of application, Hospitals and Clinics has a share about 80 percent.

Who are the main players in the Radiopharmaceutical Injector Market report?

Ans: The main players in the Radiopharmaceutical Injector Market are Medrad, Inc.(Bayer), UNIVERSAL GIKEN, Comecer, Sumitomo Heavy Industries, Tema Sinergie, Lemer Pax, BQSV

What are the Application segmentation covered in the Radiopharmaceutical Injector Market report?

Ans: The Applications covered in the Radiopharmaceutical Injector Market report are Hospitals and Clinics, R&D Institution

What are the Type segmentation covered in the Radiopharmaceutical Injector Market report?

Ans: The Types covered in the Radiopharmaceutical Injector Market report are PET Radioactive Drugs Injector, PET and SPECT Radioactive Drugs Injector

1 Radiopharmaceutical Injector Market Overview
1.1 Product Definition
1.2 Radiopharmaceutical Injector by Type
1.2.1 Global Radiopharmaceutical Injector Market Value by Type: 2025 vs 2032
1.2.2 PET Radioactive Drugs Injector
1.2.3 PET and SPECT Radioactive Drugs Injector
1.3 Radiopharmaceutical Injector by Application
1.3.1 Global Radiopharmaceutical Injector Market Value by Application: 2025 vs 2032
1.3.2 Hospitals and Clinics
1.3.3 R&D Institution
1.4 Global Radiopharmaceutical Injector Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceutical Injector Revenue 2021–2032
1.4.2 Global Radiopharmaceutical Injector Sales 2021–2032
1.4.3 Global Radiopharmaceutical Injector Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Radiopharmaceutical Injector Market Competition by Manufacturers
2.1 Global Radiopharmaceutical Injector Sales Market Share by Manufacturers (2021–2026)
2.2 Global Radiopharmaceutical Injector Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Radiopharmaceutical Injector Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Radiopharmaceutical Injector, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Radiopharmaceutical Injector, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Radiopharmaceutical Injector, Product Types and Applications
2.7 Global Key Manufacturers of Radiopharmaceutical Injector, Date of Entry into the Industry
2.8 Global Radiopharmaceutical Injector Market Competitive Situation and Trends
2.8.1 Global Radiopharmaceutical Injector Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Radiopharmaceutical Injector Players Market Share by Revenue
2.8.3 Global Radiopharmaceutical Injector Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Radiopharmaceutical Injector Market Scenario by Region
3.1 Global Radiopharmaceutical Injector Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Radiopharmaceutical Injector Sales by Region: 2021–2032
3.2.1 Global Radiopharmaceutical Injector Sales by Region: 2021–2026
3.2.2 Global Radiopharmaceutical Injector Sales by Region: 2027–2032
3.3 Global Radiopharmaceutical Injector Revenue by Region: 2021–2032
3.3.1 Global Radiopharmaceutical Injector Revenue by Region: 2021–2026
3.3.2 Global Radiopharmaceutical Injector Revenue by Region: 2027–2032
3.4 North America Radiopharmaceutical Injector Market Facts & Figures by Country
3.4.1 North America Radiopharmaceutical Injector Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Radiopharmaceutical Injector Sales by Country (2021–2032)
3.4.3 North America Radiopharmaceutical Injector Revenue by Country (2021–2032)
3.4.4 Canada
3.5 Europe Radiopharmaceutical Injector Market Facts & Figures by Country
3.5.1 Europe Radiopharmaceutical Injector Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Radiopharmaceutical Injector Sales by Country (2021–2032)
3.5.3 Europe Radiopharmaceutical Injector Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Radiopharmaceutical Injector Market Facts & Figures by Region
3.6.1 Asia Pacific Radiopharmaceutical Injector Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Radiopharmaceutical Injector Sales by Region (2021–2032)
3.6.3 Asia Pacific Radiopharmaceutical Injector Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Radiopharmaceutical Injector Market Facts & Figures by Country
3.7.1 Latin America Radiopharmaceutical Injector Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Radiopharmaceutical Injector Sales by Country (2021–2032)
3.7.3 Latin America Radiopharmaceutical Injector Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Radiopharmaceutical Injector Market Facts & Figures by Country
3.8.1 Middle East and Africa Radiopharmaceutical Injector Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Radiopharmaceutical Injector Sales by Country (2021–2032)
3.8.3 Middle East and Africa Radiopharmaceutical Injector Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Radiopharmaceutical Injector Sales by Type (2021–2032)
4.1.1 Global Radiopharmaceutical Injector Sales by Type (2021–2026)
4.1.2 Global Radiopharmaceutical Injector Sales by Type (2027–2032)
4.1.3 Global Radiopharmaceutical Injector Sales Market Share by Type (2021–2032)
4.2 Global Radiopharmaceutical Injector Revenue by Type (2021–2032)
4.2.1 Global Radiopharmaceutical Injector Revenue by Type (2021–2026)
4.2.2 Global Radiopharmaceutical Injector Revenue by Type (2027–2032)
4.2.3 Global Radiopharmaceutical Injector Revenue Market Share by Type (2021–2032)
4.3 Global Radiopharmaceutical Injector Price by Type (2021–2032)
5 Segment by Application
5.1 Global Radiopharmaceutical Injector Sales by Application (2021–2032)
5.1.1 Global Radiopharmaceutical Injector Sales by Application (2021–2026)
5.1.2 Global Radiopharmaceutical Injector Sales by Application (2027–2032)
5.1.3 Global Radiopharmaceutical Injector Sales Market Share by Application (2021–2032)
5.2 Global Radiopharmaceutical Injector Revenue by Application (2021–2032)
5.2.1 Global Radiopharmaceutical Injector Revenue by Application (2021–2026)
5.2.2 Global Radiopharmaceutical Injector Revenue by Application (2027–2032)
5.2.3 Global Radiopharmaceutical Injector Revenue Market Share by Application (2021–2032)
5.3 Global Radiopharmaceutical Injector Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medrad, Inc.(Bayer)
6.1.1 Medrad, Inc.(Bayer) Company Information
6.1.2 Medrad, Inc.(Bayer) Description and Business Overview
6.1.3 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Product Portfolio
6.1.5 Medrad, Inc.(Bayer) Recent Developments/Updates
6.2 UNIVERSAL GIKEN
6.2.1 UNIVERSAL GIKEN Company Information
6.2.2 UNIVERSAL GIKEN Description and Business Overview
6.2.3 UNIVERSAL GIKEN Radiopharmaceutical Injector Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 UNIVERSAL GIKEN Radiopharmaceutical Injector Product Portfolio
6.2.5 UNIVERSAL GIKEN Recent Developments/Updates
6.3 Comecer
6.3.1 Comecer Company Information
6.3.2 Comecer Description and Business Overview
6.3.3 Comecer Radiopharmaceutical Injector Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Comecer Radiopharmaceutical Injector Product Portfolio
6.3.5 Comecer Recent Developments/Updates
6.4 Sumitomo Heavy Industries
6.4.1 Sumitomo Heavy Industries Company Information
6.4.2 Sumitomo Heavy Industries Description and Business Overview
6.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sumitomo Heavy Industries Radiopharmaceutical Injector Product Portfolio
6.4.5 Sumitomo Heavy Industries Recent Developments/Updates
6.5 Tema Sinergie
6.5.1 Tema Sinergie Company Information
6.5.2 Tema Sinergie Description and Business Overview
6.5.3 Tema Sinergie Radiopharmaceutical Injector Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Tema Sinergie Radiopharmaceutical Injector Product Portfolio
6.5.5 Tema Sinergie Recent Developments/Updates
6.6 Lemer Pax
6.6.1 Lemer Pax Company Information
6.6.2 Lemer Pax Description and Business Overview
6.6.3 Lemer Pax Radiopharmaceutical Injector Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Lemer Pax Radiopharmaceutical Injector Product Portfolio
6.6.5 Lemer Pax Recent Developments/Updates
6.7 BQSV
6.7.1 BQSV Company Information
6.7.2 BQSV Description and Business Overview
6.7.3 BQSV Radiopharmaceutical Injector Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 BQSV Radiopharmaceutical Injector Product Portfolio
6.7.5 BQSV Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radiopharmaceutical Injector Industry Chain Analysis
7.2 Radiopharmaceutical Injector Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radiopharmaceutical Injector Production Mode & Process Analysis
7.4 Radiopharmaceutical Injector Sales and Marketing
7.4.1 Radiopharmaceutical Injector Sales Channels
7.4.2 Radiopharmaceutical Injector Distributors
7.5 Radiopharmaceutical Injector Customer Analysis
8 Radiopharmaceutical Injector Market Dynamics
8.1 Radiopharmaceutical Injector Industry Trends
8.2 Radiopharmaceutical Injector Market Drivers
8.3 Radiopharmaceutical Injector Market Challenges
8.4 Radiopharmaceutical Injector Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Radiopharmaceutical Injector Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Radiopharmaceutical Injector Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Radiopharmaceutical Injector Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Radiopharmaceutical Injector Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Radiopharmaceutical Injector Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Radiopharmaceutical Injector Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Radiopharmaceutical Injector Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Radiopharmaceutical Injector Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Radiopharmaceutical Injector, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Radiopharmaceutical Injector, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Radiopharmaceutical Injector, Product Types and Applications
 Table 12. Global Key Manufacturers of Radiopharmaceutical Injector, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Radiopharmaceutical Injector Companies by Tier (Tier 1, Tier 2, Tier 3), based on Radiopharmaceutical Injector Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Radiopharmaceutical Injector Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Radiopharmaceutical Injector Sales by Region (Units), 2021–2026
 Table 18. Global Radiopharmaceutical Injector Sales Market Share by Region (2021–2026)
 Table 19. Global Radiopharmaceutical Injector Sales by Region (Units), 2027–2032
 Table 20. Global Radiopharmaceutical Injector Sales Market Share by Region (2027–2032)
 Table 21. Global Radiopharmaceutical Injector Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Radiopharmaceutical Injector Revenue Market Share by Region (2021–2026)
 Table 23. Global Radiopharmaceutical Injector Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Radiopharmaceutical Injector Revenue Market Share by Region (2027–2032)
 Table 25. North America Radiopharmaceutical Injector Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Radiopharmaceutical Injector Sales by Country (Units), 2021–2026
 Table 27. North America Radiopharmaceutical Injector Sales by Country (Units), 2027–2032
 Table 28. North America Radiopharmaceutical Injector Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Radiopharmaceutical Injector Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Radiopharmaceutical Injector Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Radiopharmaceutical Injector Sales by Country (Units), 2021–2026
 Table 32. Europe Radiopharmaceutical Injector Sales by Country (Units), 2027–2032
 Table 33. Europe Radiopharmaceutical Injector Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Radiopharmaceutical Injector Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Radiopharmaceutical Injector Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Radiopharmaceutical Injector Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Radiopharmaceutical Injector Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Radiopharmaceutical Injector Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Radiopharmaceutical Injector Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Radiopharmaceutical Injector Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Radiopharmaceutical Injector Sales by Country (Units), 2021–2026
 Table 42. Latin America Radiopharmaceutical Injector Sales by Country (Units), 2027–2032
 Table 43. Latin America Radiopharmaceutical Injector Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Radiopharmaceutical Injector Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Radiopharmaceutical Injector Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Radiopharmaceutical Injector Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Radiopharmaceutical Injector Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Radiopharmaceutical Injector Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Radiopharmaceutical Injector Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Radiopharmaceutical Injector Sales (Units) by Type (2021–2026)
 Table 51. Global Radiopharmaceutical Injector Sales (Units) by Type (2027–2032)
 Table 52. Global Radiopharmaceutical Injector Sales Market Share by Type (2021–2026)
 Table 53. Global Radiopharmaceutical Injector Sales Market Share by Type (2027–2032)
 Table 54. Global Radiopharmaceutical Injector Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Radiopharmaceutical Injector Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Radiopharmaceutical Injector Revenue Market Share by Type (2021–2026)
 Table 57. Global Radiopharmaceutical Injector Revenue Market Share by Type (2027–2032)
 Table 58. Global Radiopharmaceutical Injector Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Radiopharmaceutical Injector Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Radiopharmaceutical Injector Sales (Units) by Application (2021–2026)
 Table 61. Global Radiopharmaceutical Injector Sales (Units) by Application (2027–2032)
 Table 62. Global Radiopharmaceutical Injector Sales Market Share by Application (2021–2026)
 Table 63. Global Radiopharmaceutical Injector Sales Market Share by Application (2027–2032)
 Table 64. Global Radiopharmaceutical Injector Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Radiopharmaceutical Injector Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Radiopharmaceutical Injector Revenue Market Share by Application (2021–2026)
 Table 67. Global Radiopharmaceutical Injector Revenue Market Share by Application (2027–2032)
 Table 68. Global Radiopharmaceutical Injector Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Radiopharmaceutical Injector Price (US$/Unit) by Application (2027–2032)
 Table 70. Medrad, Inc.(Bayer) Company Information
 Table 71. Medrad, Inc.(Bayer) Description and Business Overview
 Table 72. Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Medrad, Inc.(Bayer) Radiopharmaceutical Injector Product
 Table 74. Medrad, Inc.(Bayer) Recent Developments/Updates
 Table 75. UNIVERSAL GIKEN Company Information
 Table 76. UNIVERSAL GIKEN Description and Business Overview
 Table 77. UNIVERSAL GIKEN Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. UNIVERSAL GIKEN Radiopharmaceutical Injector Product
 Table 79. UNIVERSAL GIKEN Recent Developments/Updates
 Table 80. Comecer Company Information
 Table 81. Comecer Description and Business Overview
 Table 82. Comecer Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Comecer Radiopharmaceutical Injector Product
 Table 84. Comecer Recent Developments/Updates
 Table 85. Sumitomo Heavy Industries Company Information
 Table 86. Sumitomo Heavy Industries Description and Business Overview
 Table 87. Sumitomo Heavy Industries Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Sumitomo Heavy Industries Radiopharmaceutical Injector Product
 Table 89. Sumitomo Heavy Industries Recent Developments/Updates
 Table 90. Tema Sinergie Company Information
 Table 91. Tema Sinergie Description and Business Overview
 Table 92. Tema Sinergie Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Tema Sinergie Radiopharmaceutical Injector Product
 Table 94. Tema Sinergie Recent Developments/Updates
 Table 95. Lemer Pax Company Information
 Table 96. Lemer Pax Description and Business Overview
 Table 97. Lemer Pax Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Lemer Pax Radiopharmaceutical Injector Product
 Table 99. Lemer Pax Recent Developments/Updates
 Table 100. BQSV Company Information
 Table 101. BQSV Description and Business Overview
 Table 102. BQSV Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. BQSV Radiopharmaceutical Injector Product
 Table 104. BQSV Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Radiopharmaceutical Injector Distributors List
 Table 108. Radiopharmaceutical Injector Customers List
 Table 109. Radiopharmaceutical Injector Market Trends
 Table 110. Radiopharmaceutical Injector Market Drivers
 Table 111. Radiopharmaceutical Injector Market Challenges
 Table 112. Radiopharmaceutical Injector Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Radiopharmaceutical Injector
 Figure 2. Global Radiopharmaceutical Injector Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Radiopharmaceutical Injector Market Share by Type: 2025 & 2032
 Figure 4. PET Radioactive Drugs Injector Product Picture
 Figure 5. PET and SPECT Radioactive Drugs Injector Product Picture
 Figure 6. Global Radiopharmaceutical Injector Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Radiopharmaceutical Injector Market Share by Application: 2025 & 2032
 Figure 8. Hospitals and Clinics
 Figure 9. R&D Institution
 Figure 10. Global Radiopharmaceutical Injector Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Radiopharmaceutical Injector Market Size (US$ Million), 2021–2032
 Figure 12. Global Radiopharmaceutical Injector Sales (Units), 2021–2032
 Figure 13. Global Radiopharmaceutical Injector Average Price (US$/Unit), 2021–2032
 Figure 14. Radiopharmaceutical Injector Report Years Considered
 Figure 15. Radiopharmaceutical Injector Sales Share by Manufacturers in 2025
 Figure 16. Global Radiopharmaceutical Injector Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Radiopharmaceutical Injector Players: Market Share by Revenue in Radiopharmaceutical Injector in 2025
 Figure 18. Radiopharmaceutical Injector Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Radiopharmaceutical Injector Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Radiopharmaceutical Injector Sales Market Share by Country (2021–2032)
 Figure 21. North America Radiopharmaceutical Injector Revenue Market Share by Country (2021–2032)
 Figure 22. Canada Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Europe Radiopharmaceutical Injector Sales Market Share by Country (2021–2032)
 Figure 24. Europe Radiopharmaceutical Injector Revenue Market Share by Country (2021–2032)
 Figure 25. Germany Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. France Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. U.K. Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Italy Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Russia Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Asia Pacific Radiopharmaceutical Injector Sales Market Share by Region (2021–2032)
 Figure 31. Asia Pacific Radiopharmaceutical Injector Revenue Market Share by Region (2021–2032)
 Figure 32. China Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Japan Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. South Korea Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. India Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Australia Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. China Taiwan Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Southeast Asia Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Latin America Radiopharmaceutical Injector Sales Market Share by Country (2021–2032)
 Figure 40. Latin America Radiopharmaceutical Injector Revenue Market Share by Country (2021–2032)
 Figure 41. Mexico Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Brazil Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Argentina Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Middle East and Africa Radiopharmaceutical Injector Sales Market Share by Country (2021–2032)
 Figure 45. Middle East and Africa Radiopharmaceutical Injector Revenue Market Share by Country (2021–2032)
 Figure 46. Turkey Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. UAE Radiopharmaceutical Injector Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Global Sales Market Share of Radiopharmaceutical Injector by Type (2021–2032)
 Figure 50. Global Revenue Market Share of Radiopharmaceutical Injector by Type (2021–2032)
 Figure 51. Global Radiopharmaceutical Injector Price (US$/Unit) by Type (2021–2032)
 Figure 52. Global Sales Market Share of Radiopharmaceutical Injector by Application (2021–2032)
 Figure 53. Global Revenue Market Share of Radiopharmaceutical Injector by Application (2021–2032)
 Figure 54. Global Radiopharmaceutical Injector Price (US$/Unit) by Application (2021–2032)
 Figure 55. Radiopharmaceutical Injector Value Chain
 Figure 56. Channels of Distribution (Direct Vs Distribution)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String